Golden
Advent Venture Partners

Advent Venture Partners

Advent Venture Partners is one of Europe's growth and venture capital investors in tech and life sciences businesses.

Advent Venture Partners is a venture capital and private equity firm specializing in startups, seed, early, mid-stage, late venture, emerging growth investments, later stage, buyout, and growth capital investments.

History

Advent Venture Partners is a firm investing in tech and life sciences businesses. It is based in London and was founded in 1981.

Advent Venture Partners is a privately held venture capital & private equity company. It operates in the following areas: venture capital, growth capital, technology, digital media, e-commerce, internet, mobile, software, cleantech, consumer, life sciences, biotech, biopharma, medical devices, platform technologies, and financing.

Services

The firm prefers to invest in innovative life sciences, telecommunication services, utilities, and information technology sectors. In innovative life sciences, it prefers to invest in diagnostics, biopharmaceuticals, medical device research and development, pharmaceuticals, platform technologies, and companies seeking to develop breakthrough products for unmet medical needs with a special focus on new drug discovery- small molecules, biologics and new modalities including med tech, enabling technologies and vaccines. In information technology, the firm focuses on communications, clean technology, digital media & Internet, e-commerce, semiconductor & components, and software & services.

Investments

Advent Venture Partners has made 78 investments as of February 2019.It has had 27 exits. The most notable exits include Farfetch, WorldStores, and Dailymotion.

Advent Venture Partners has raised a total of $492.6M across 3 funds. The Advent Life Sciences Fund II LP was announced on Sep 10, 2014, and raised a total of $146.3M.

It focuses on investments in the United Kingdom, Western European, Europe, and the United States. Within Western European markets, it prefers to invest in Andorra, Portugal, and Spain. Within Utilities, it prefers to invest in Alternate energy Resources, Independent power producers, and energy traders.

The firm typically invests between £5 million ($9.46 million) and £15 million ($29 million) in its portfolio companies. Its technology investments focus on startups with sales above €4 million ($5.7 million) and which are often seeking external capital for the first time. For information technology investments, the firm prefers to take small minority positions to full buyouts and a majority stake in a portfolio company. It seeks to take a board seat in its portfolio companies.

Timeline

March 2, 2015

WorldStores

Series D - WorldStores

£25M

September 9, 2014

Advent Life Sciences Fund II LP

$146.3M

April 30, 2014

Farfetch

Series D - Farfetch

$66M

October 7, 2013

Versartis

Series D - Versartis

$20M

August 19, 2013

Acutus Medical

Series B - Acutus Medical

$28M

July 21, 2013

Versartis

Series C - Versartis

$12.5M

June 2, 2013

WorldStores

Series C - WorldStores

$15.2M

March 2, 2013

Farfetch

Series C - Farfetch

$20M

January 14, 2013

Versartis

Series C - Versartis

$25M

December 18, 2012

NeRRe Therapeutics

Series A - NeRRe Therapeutics

$18.4M

September 4, 2012

F2G

Venture Round - F2G

$30M

November 23, 2010

Life sciences fund I

$120M

December 14, 2005

Advent Private Equity Fund IV

£128M

Funded Companies

20 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location
Funding rounds
Funding rounds
A company developing robotic endoscopic technology for transluminal endoscopic surgery
A molecular diagnostics company developing technologies for the detection, quantification and amplification of bio-analytes
A biopharmaceutical company developing small molecule drugs for asthma, chronic allergy and inflammatory conditions

People

Name
Role
LinkedIn

Alain Huriez





Alan E. Walts

Venture Partner



Andrew J Wood

Venture Partner



Dale Pfost

General Partner



Don Drakeman

Venture Partner



Ian J. Nicholson

Operating Partner



John Rex

Operating Partner



Jon Moore

Operating Partner



Kaasim Mahmood

General Partner



Mary Kerr

Operating Partner



Naseem Amin

Venture Partner



Raj Parekh

General Partner



Roy Lobb

Venture Partner



Shahzad Malik

General Partner



Simon Kerry

Operating Partner



Steve Butcher

Operating Partner



Further reading

Title
Author
Link
Type
Date

A French VC Shows off a New Fund -- and Growing Interest in Europe



Web



Advent gears up for launch of third life sciences fund | Unquote



Web



Advent Venture Partners Announces Final Close of First Life Sciences Venture Fund | FierceBiotech



Web



Advent Venture Partners Start Life Science Fund with $118M



Web



Fashion Marketplace Farfetch Raises $86M Led By DST At A $1B Valuation



Web



Felix Capital At The Intersection Of Creativity And Tech - Informilo



Web



Fizzback bags $5m from Advent Venture Partners - Econsultancy



Web



Fred Destin of Accel Partners on What's Changing (Fast) in Europe



Web



Future Of Cancer Treatment: Immunotherapy Startups Take Lion's Share of Oncology Deals



Web



Investment in Farfetch.com by Advent Venture Partners



Web



Markham Rae Appoints Kah Chye Tan and Sir David Cooksey to Markham Rae Trade Capital Partners Advisory Board

Markham Rae (UK) Ltd.

Web



Petroni Vineyards Grows from Humble Roots to Become the Ultimate Sonoma Wine Destination



Web



The International Unicorn Club: 107 Private Companies Outside The US Valued At $1B+



Web



With Felix Capital, Frederic Court brings Silicon Valley-style investment to Europe



Web



Documentaries, videos and podcasts

Title
Date
Link

Frederic Court Interview - video dailymotion



RANKED: The 22 biggest European venture capital firms in 2016



What Big Ideas are VC's Betting on in Digital Advertising - video dailymotion



Companies

Company
CEO
Location
Products/Services













Aleta Biotherapeutics







Algeta







Alpha Anomeric













Artax Biopharma













Avila







Axonics Modulation Technologies







Biocartis







Calcico Therapeutics







Capella Biosciences







CardiacAssist







CardioKine







Cellnovo







CN Creative













EUSA Pharma







F2G







GMP-Orphan













References